Alice K. Pau

4.0k citations

60 papers · 2.7k indexed · 1 hit paper · h-index 20

Co-authors: Henry Masur King K. Holmes Constance A. Benson Jonathan E. Kaplan John T. Brooks Jomy George Anthony S. Fauci J. T. Brooks
Topics: HIV/AIDS drug development and treatment (31 papers)Pneumocystis jirovecii pneumonia detection and treatment (19 papers)HIV Research and Treatment (19 papers)
Cited by: Virology Infectious Diseases Epidemiology
Journals: Proceedings of the National Academy of Sciences JAMA Annals of Internal Medicine
Partner nations: United States Israel Kenya

In The Last Decade

Alice K. Pau

58 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America

2009 1000 citations Alice K. Pau, Henry Masur et al. profile →

Peers

Countries citing papers authored by Alice K. Pau

Since Specialization

Citations

This map shows the geographic impact of Alice K. Pau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice K. Pau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice K. Pau more than expected).

Fields of papers citing papers by Alice K. Pau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice K. Pau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice K. Pau. The network helps show where Alice K. Pau may publish in the future.

Co-authorship network of co-authors of Alice K. Pau

This figure shows the co-authorship network connecting the top 25 collaborators of Alice K. Pau. A scholar is included among the top collaborators of Alice K. Pau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice K. Pau. Alice K. Pau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Statin Therapy as Primary Prevention for Persons With HIV: A Synopsis of Recommendations From the U.S. Department of Health and Human Services Antiretroviral Treatment Guidelines Panel 2025 ·Annals of Internal Medicine ·Craig J. Beavers,Alice K. Pau,David V. Glidden,Emily P. Hyle,Safia Kuriakose,Seth S. Martin,Grace A. McComsey,Melanie Thompson,Salim S. Virani,Jason V. Baker	4
2	Ex vivo sensitivity to broadly neutralizing antibodies and anti-CD4 antibody UB-421 of infectious viral isolates from people living with multidrug-resistant HIV 2024 ·EBioMedicine ·Mohammad Ali,Jana Blažková,J. Shawn Justement,Victoria Shi,(unknown),(unknown),Mary McLaughlin,Michael C. Sneller,Alice K. Pau,Susan Moir,Tae‐Wook Chun	0
3	Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19 2021 ·Annals of Internal Medicine ·Safia Kuriakose,(unknown),Alice K. Pau,Eric S. Daar,Rajesh T. Gandhi,Pablo Tebas,Laura Evans,Roy M. Gulick,H. Clifford Lane,Henry Masur	13
4	The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West Africa 2021 ·PLoS ONE ·Moses J Soka,(unknown),Collin Van Ryn,Greg Grandits,Alice K. Pau,Moses Badio,Stephen B. Kennedy,Michael C. Sneller,Elizabeth S. Higgs,H. Clifford Lane,Mosoka Fallah,Stephen A. Migueles,Cavan Reilly	3
5	Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel 2020 ·Annals of Internal Medicine ·Alice K. Pau,Judith A. Aberg,(unknown),Pamela S. Belperio,Craig Coopersmith,Page Crew,Birgit Grund,Roy M. Gulick,Carly Harrison,Arthur Kim,H. Clifford Lane,Henry Masur,Virginia Sheikh,(unknown),Jinoos Yazdany,Pablo Tebas	29
6	Early Presence of HIV-1 Subtype C in Washington, D.C. 2018 ·AIDS Research and Human Retroviruses ·Zehava Grossman,(unknown),(unknown),Wei Shao,Catherine Rehm,Sara R. Jones,Giorgio Bozzi,(unknown),Robin Dewar,Tauseef Ur Rehman,Julia Purdy,Colleen Hadigan,Alice K. Pau,Frank Maldarelli	3
7	Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects 2016 ·Clinical Infectious Diseases ·(unknown),Scott Penzak,Alice K. Pau,Parag Kumar,(unknown),Raul M. Alfaro,Joseph A. Kovacs	9
8	Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients 2015 ·AIDS Research and Human Retroviruses ·Philip Grant,Virginia Sheikh,Rebecca DerSimonian,Adam Rupert,Gregg Roby,Alice K. Pau,Michael C. Sneller,(unknown),Todd T. Brown,Irini Sereti	1
9	Influence of Low-Dose Ritonavir With and Without Darunavir on the Pharmacokinetics and Pharmacodynamics of Inhaled Beclomethasone 2013 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown),Colleen Hadigan,(unknown),Cheryl Chairez,Lynnette K. Nieman,Alice K. Pau,Raul M. Alfaro,Joseph A. Kovacs,(unknown),Scott Penzak	29
10	Genotypic Resistance at Viral Rebound Among Patients Who Received Lopinavir/Ritonavir-Based or Efavirenz-Based First Antiretroviral Therapy in South Africa 2011 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown),Zonghui Hu,Johanna Ledwaba,Lynn Morris,Frank Maldarelli,Robin Dewar,(unknown),(unknown),(unknown),Dean Follmann,Alice K. Pau	13
11	d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS 2010 ·Clinical Immunology ·Brian Porter,(unknown),Jessica N. Hodge,Margo A. Smith,Alice K. Pau,Gregg Roby,Richard Kwan,Rachel Bishop,Catherine Rehm,JoAnn M. Mican,Irini Sereti	37
12	Recognition and Management of Significant Drug Interactions in HIV Patients: Challenges in Using Available Data to Guide Therapy 2010 ·Clinical Pharmacology & Therapeutics ·Alice K. Pau,(unknown)	11
13	Drug interactions in the management of HIV infection: an update 2007 ·Expert Opinion on Pharmacotherapy ·Sarah Robertson,Scott Penzak,Alice K. Pau	22
14	Predictors for Hematopoietic Growth Factors Use in HIV/HCV-Coinfected Patients Treated with Peginterferon Alfa 2b and Ribavirin 2006 ·AIDS Patient Care and STDs ·Alice K. Pau,(unknown),Zonghui Hu,(unknown),Michael A. Polis,Shyam Kottilil	6
15	Drug interactions in the management of HIV infection 2005 ·Expert Opinion on Pharmacotherapy ·Sarah Robertson,Scott Penzak,Alice K. Pau	15
16	Instability of lopinavir/ritonavir capsules at ambient temperatures in sub-Saharan Africa: relevance to WHO antiretroviral guidelines 2005 ·AIDS ·Alice K. Pau,(unknown),Diane T. Holland,Henry Fomundam,(unknown),Edmund V. Capparelli	6
17	A Potentially Significant Interaction between Efavirenz and Phenytoin: A Case Report and Review of the Literature 2005 ·Clinical Infectious Diseases ·Sarah Robertson,Scott Penzak,Jason Lane,Alice K. Pau,JoAnn M. Mican	19
18	Antiretroviral therapy-associated serious and life-threatening toxicities 2003 ·Current Infectious Disease Reports ·Alice K. Pau	4
19	HIV-Associated Non-Hodgkin Lymphoma 2001 ·JAMA ·Richard F. Little,Martin Gutierrez,Elaine S. Jaffe,Alice K. Pau,Malcolm Horne,(unknown)	54
20	The Effect of Ritonavir on the Pharmacokinetics of Meperidine and Normeperidine 2000 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Stephen C. Piscitelli,(unknown),Richard Bertz,Alice K. Pau,Richard T. Davey	24

About Alice K. Pau

Alice K. Pau is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 60 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (31 papers), Pneumocystis jirovecii pneumonia detection and treatment (19 papers) and HIV Research and Treatment (19 papers). The work is most often cited by research in Virology (632 citations), Infectious Diseases (1.5k citations) and Epidemiology (1.4k citations). Alice K. Pau has collaborated with scholars based in United States, Israel and Kenya. Frequent co-authors include Henry Masur, King K. Holmes, Constance A. Benson, Jonathan E. Kaplan, John T. Brooks, Jomy George, Anthony S. Fauci, J. T. Brooks, John Kaplan and Mark Dybul. Their work appears in journals such as Proceedings of the National Academy of Sciences, JAMA and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact